Www1.health.gov.au

'discount' available to pharmacy on chemothera py drugs remained relatively static until the Docetaxel reduction in Dec-12. This allowed the continuation of pharmacy supporting the cost of providing chemotherapy services by cross­ subsidising the on-patent drugs with the higher margin from a small number of off-patent drugs. ................
................